Pharvaris PHVS
NASDAQ PHVS
$36.14 +0.48 (+1.35%)
As of: Sep 4, 2026 · 1:40 PM EDT

Pharvaris (PHVS) Property, Plant & Equipment (Net) Growth (5y) (2024 - 2026)

Analysis

Pharvaris (PHVS) Property, Plant & Equipment (Net) Growth (5y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Pharvaris 2.14 Bn 1.77 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,240.16%
Mar 31, 2026 2,471.61%
Dec 31, 2025 2,544.44%
Dec 31, 2024 118.51%